Immuneering Corporation

NASDAQ:IMRX

Biotechnology

Healthcare
$3.46 -0.14%

-$0.01 today

Market cap
$224.08M
Beta
0.38
P/E (TTM)
-3.6
EPS (TTM)
-$1.24
52W Low $2.29High $10.08

Volume 1.25M

Average 1.38M

Price history

Immuneering Corporation SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-51.61%

Period high

$8.33

Period low

$3.37

Latest

$3.46

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 9, 2026Nov 9, 2026
4Nov 9, 2026Nov 9, 2026
3Nov 9, 2026Nov 9, 2026
10-QOct 29, 2026Oct 29, 2026
8-KOct 29, 2026Oct 29, 2026
8-KAug 5, 2026Aug 5, 2026
10-QAug 5, 2026Aug 5, 2026
SC 13GJul 28, 2026Jul 28, 2026
4Jul 17, 2026Jul 17, 2026
3Jul 16, 2026Jul 16, 2026
4Jun 24, 2026Jun 24, 2026
4Jun 16, 2026Jun 16, 2026
8-KJun 15, 2026Jun 15, 2026
4Jun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026

Competitors

Who does Immuneering Corporation compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about IMRX's filings, answered from its disclosures.

What is the latest IMRX filing?

The latest filing shown is 8-K dated Nov 9, 2026.

How many recent filings does IMRX have?

Intrinsic Alpha currently shows 20 recent filings for IMRX.